Clinical Trial

A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus

Name: A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus — clinical trial record (NCT07509892)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To assess the efficacy and safety of TQH3906 in treating systemic lupus erythematosus.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-09

Trial Details

NCT Number	NCT07509892
Lead Sponsor	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions	Systemic Lupus Erythematosus
Enrollment	198 participants
Start Date	2026-06-22
Primary Completion	2027-11 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-07-08